National American University Holdings, Inc.

Similar documents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP

INTERNATIONAL WIRE GROUP INC Filed by BLACKSTONE DISTRESSED SECURITIES ADVISORS LP

FEDERAL DEPOSIT INSURANCE CORPORATION WASHINGTON, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SCHEDULE 13G (Amendment No. )

SCHEDULE 13G. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Under the Securities Exchange Act of (Amendment No.

Twilio, Inc. (Name of Issuer)

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO.

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

Tallgrass Energy GP, LP (Name of Issuer)

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

Netlist, Inc. (Name of Issuer)

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

GOPHER PROTOCOL INC. Filed by FLEMING STEPHEN M.

Tallgrass Energy Partners, LP (Name of Issuer)

<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Realogy Holdings Corp. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

NICE SYSTEMS LTD Filed by PSAGOT INVESTMENT HOUSE LTD.

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

STRAIGHT PATH COMMUNICATIONS INC. Filed by MILLER LLOYD I III

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934

Floor & Décor Holdings, Inc. (Name of Issuer)

SCHEDULE 13G* (Rule 13d-102) Corbus Pharmaceuticals Holdings, Inc. (Name of Issuer)

STRAYER EDUCATION INC Filed by AXA FINANCIAL INC

OCI PARTNERS LP Filed by OCI N.V.

ECO-STIM ENERGY SOLUTIONS, INC. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC

GLOBUS MEDICAL INC Filed by PAUL DAVID C

GENCO SHIPPING & TRADING LTD Filed by OZ MANAGEMENT LP

Section 1: SC 13G/A (SC 13G/A)

SECURITIES AND EXCHANGE COMMISSION Washington, DC SCHEDULE 13G (Rule 13d-102)

ACCESS INTEGRATED TECHNOLOGIES INC

Senseonics Holdings, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Rule 13d-102)

Sientra, Inc. (Name of Issuer)

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

FORBES ENERGY SERVICES LTD. Filed by WEST FACE CAPITAL INC.

KINGSTONE COMPANIES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

AMBOW EDUCATION HOLDING LTD. Filed by GIC PRIVATE LTD

NEVADA GOLD & CASINOS INC Filed by HABERKORN STEPHEN J

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

Carvana Co. (Name of Issuer)

XILINX INC Filed by VANGUARD GROUP INC

COMCAST CORP Filed by MICROSOFT CORP

Recro Pharma, Inc. (Name of Issuer)

PENN VIRGINIA CORPORATION (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Realogy Holdings Corp.

HAWK SYSTEMS, INC. Filed by GREYSTONE BUSINESS CREDIT II, L.L.C.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Amendment No. ) Under the Securities Exchange Act of 1934

Silvercrest Asset Management Group Inc. (Name of Issuer)

American Midstream Partners, LP (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

EXFO INC. FORM SC 13G/A. (Amended Statement of Ownership) Filed 01/19/12

Propetro Holding Corp. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of SEACOR Holdings Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Alliqua BioMedical, Inc. (Name of Issuer)

Cocrystal Pharma, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

Alliqua BioMedical, Inc.

SECURITIES AND EXCHANGE COMMISSION FORM SC 13G. Filing Date: SEC Accession No (HTML Version on secdatabase.

MOODYS CORP /DE/ Filed by CHILDRENS INVESTMENT FUND MANAGEMENT (UK) LLP

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

united StateS SeCuritieS and exchange COMMiSSiOn Washington, D.C SCHeDuLe 13g

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Transcription:

SECURITIES & EXCHANGE COMMISSION EDGAR FILING National American University Holdings, Inc. Form: SC 13G Date Filed: 218-1-22 Corporate Issuer CIK: 1399855 Copyright 218, Issuer Direct Corporation. All Right Reserved. Distribution of this document is strictly prohibited, subject to the terms of use.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 Under the Securities Exchange Act of 1934 (Amendment No. n/a)* National American University Holdings, Inc. (Name of Issuer) Common Stock, par value $.1 per share (Title of Class of Securities) 63245Q15 (CUSIP Number) January 17, 218 (Date of Event Which Requires Filing this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 63245Q15 1. Names of Reporting Persons Camden Partners III SPV, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware 5. Sole Voting Power Number of Shares Beneficially Owned by Each Reporting Person With: 6. Shared Voting Power 7. Sole Dispositive Power 8. Shared Dispositive Power 9. Aggregate Amount Beneficially Owned by Each Reporting Person

1. Check if the Aggregate Amount in Row (9) Excludes Certain Shares 11. Percent of Class Represented by Amount in Row (9) 9.% 12. Type of Reporting Person (See Instructions) PN 2 CUSIP No. 63245Q15 1. Names of Reporting Persons 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware 5. Sole Voting Power Number of Shares Beneficially Owned by Each Reporting Person With: 6. Shared Voting Power 7. Sole Dispositive Power 8. Shared Dispositive Power 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1. Check if the Aggregate Amount in Row (9) Excludes Certain Shares 11. Percent of Class Represented by Amount in Row (9) 9.% 12. Type of Reporting Person (See Instructions) OO 3 CUSIP No. 63245Q15 1. Names of Reporting Persons J. Todd Sherman 2. Check the Appropriate Box if a Member of a Group (See Instructions)

(a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization United States 5. Sole Voting Power Number of Shares Beneficially Owned by Each Reporting Person With: 6. Shared Voting Power 7. Sole Dispositive Power 8. Shared Dispositive Power 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1. Check if the Aggregate Amount in Row (9) Excludes Certain Shares 11. Percent of Class Represented by Amount in Row (9) 9.% 12. Type of Reporting Person (See Instructions) IN 4 CUSIP No. 63245Q15 1. Names of Reporting Persons David L. Warnock 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization United States 5. Sole Voting Power Number of Shares Beneficially Owned by Each Reporting Person With: 6. Shared Voting Power 7. Sole Dispositive Power

8. Shared Dispositive Power 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1. Check if the Aggregate Amount in Row (9) Excludes Certain Shares 11. Percent of Class Represented by Amount in Row (9) 9.% 12. Type of Reporting Person (See Instructions) IN 5 CUSIP No. 63245Q15 Item 1(a) Name of Issuer: National American University Holdings, Inc. (the Issuer ) Item 1(b) Address of Issuer s Principal Executive Offices: 531 Mt. Rushmore Road Rapid City, South Dakota 5771 Item 2(a) Names of Persons Filing: This Schedule 13G is being jointly filed by and on behalf of each of Camden Partners III SPV, L.P., a Delaware limited partnership ( Camden Partners ),, a Delaware limited liability company and the general partner of Camden Partners ( Camden GP ), J. Todd Sherman, a manager of Camden GP ( Sherman ), and David L. Warnock, a manager of Camden GP ( Warnock ). Camden Partners, Camden Partners GP, Sherman and Warnock are collectively referred to herein as the Reporting Persons. Camden Partners is the direct beneficial owner of the securities covered by this statement. Camden Partners GP, as the general partner of Camden Partners, and Sherman and Warnock, as the managers of the Camden Partners GP, each may be deemed to beneficially own securities held directly by Camden Partners. The Reporting Persons have entered into a Joint Filing Agreement, dated January 22, 218, a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k) (1) under the Securities Exchange Act of 1934, as amended. Item 2(b) Address or principal business office or, if none, residence: The address for each of the Reporting Persons is: c/o Camden Partners Holdings, LLC 5 East Pratt Street Suite 12 Baltimore, Maryland 2122 Item 2(c) Citizenship: Camden Partners Delaware 6 CUSIP No. 63245Q15 Camden Partners GP Delaware Sherman United States Warnock United States Item 2(d) Title of class of securities:

Common Stock, par value $.1 per share ( Common Stock ) Item 2(e) CUSIP No.: 63245Q15 Item 3. If this statement is filed pursuant to 24.13d-1(b) or 24.13d-2(b) or (c), check whether the person filing is a: Item 4. Ownership: For each Reporting Person: (a) Amount beneficially owned: shares of Common Stock (b) Percent of class: 9.% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: (ii) Shared power to vote or to direct the vote: (iii) Sole power to dispose or to direct the disposition of: (iv) Shared power to dispose or to direct the disposition of: The percentages used in this Schedule 13G are calculated based upon the Issuer s 24,31,482 issued and outstanding shares of Common Stock as of December 28, 217, as reported in the Issuer s Quarterly Report on Form 1-Q filed with the Securities and Exchange Commission on January 5, 218. Camden Partners GP, as the general partner of Camden Partners, and Sherman and Warnock, as the managers of the Camden Partners GP, each may be deemed to beneficially own securities held directly by Camden Partners. 7 CUSIP No. 63245Q15 Item 5. Ownership of 5 Percent or Less of a Class: Item 6. Ownership of More than 5 Percent on Behalf of Another Person: Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person: Item 8. Identification and Classification of Members of the Group : Item 9. Notice of Dissolution of Group: Item 1. Certifications: By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 22, 218 Camden Partners III SPV, L.P.

Its: General Partner Name: J. Todd Sherman Title: Manager Name: J. Todd Sherman Title: Manager J. Todd Sherman 9 J. Todd Sherman, as Attorney-in-Fact for David L. Warnock CUSIP No. 63245Q15 EXHIBIT INDEX Exhibit 1 Joint Filing Agreement, dated as of January 22, 218, by and among Camden Partners III SPV, L.P.,, J. Todd Sherman and David L. Warnock, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. 1

Exhibit 1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. Dated: January 22, 218 Camden Partners III SPV, L.P. Its: General Partner Name: J. Todd Sherman Title: Manager Name: J. Todd Sherman Title: Manager J. Todd Sherman J. Todd Sherman, as Attorney-in-Fact for David L. Warnock